Stay updated on LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial

Sign up to get notified when there's something new on the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.2 to v3.5.3, reflecting a software/version release rather than any modification to the trial record.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:39.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision history shows a new latest version: v3.5.2, replacing v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:06.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0. The update does not modify the study record data or history.
    Difference
    0.1%
    Check dated 2026-03-19T05:16:19.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:47.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version history shows updates to the Study Status, Recruitment Status, and Contacts/Locations sections, with several items added or removed. The newer version also introduces an IPD Sharing entry and other sponsor/locations edits.
    Difference
    0.1%
    Check dated 2026-02-18T16:30:36.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The history shows a new revision v3.4.2 has been added; the government funding notice and the previous revision v3.4.1 were removed.
    Difference
    0.6%
    Check dated 2026-02-11T11:30:59.000Z thumbnail image

Stay in the know with updates to LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page.